U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease. The Food and Drug Administration (FDA) said it granted approval to the drug from Biogen based on results that seemed 鈥渞easonably likely鈥� to benefit Alzheimer's patients. ()
Category:
Published on: 10 Jun 2021
